Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona).

EBioMedicine·2024
Same author

Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study.

Brain : a journal of neurology·2024
Same author

Role of Direct Sexual Contact in Human Transmission of Monkeypox Virus, Italy.

Emerging infectious diseases·2024
Same author

Saliva Is a Sensitive and Accessible Sample Both for SARS-CoV-2 Detection and for the Evaluation of Treatment Effectiveness in Follow-Up Studies.

Viruses·2024
Same author

Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.

Vaccines·2024
Same author

HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21.

The Journal of antimicrobial chemotherapy·2024

Related Experiment Video

Updated: May 29, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
04:40

Venous Thrombosis Assay in a Mouse Model of Cancer

Published on: January 5, 2024

HIV-Associated Venous Thromboembolism.

Michele Bibas1, Gianluigi Biava, Andrea Antinori

  • 1Clinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy.

Mediterranean Journal of Hematology and Infectious Diseases
|August 27, 2011
PubMed
Summary
This summary is machine-generated.

Human Immunodeficiency Virus (HIV) infection significantly increases the risk of venous thromboembolism (VTE). Physicians must monitor HIV patients for thrombotic events and manage anticoagulation carefully due to drug interactions.

More Related Videos

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

Related Experiment Videos

Last Updated: May 29, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
04:40

Venous Thrombosis Assay in a Mouse Model of Cancer

Published on: January 5, 2024

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

Area of Science:

  • Internal Medicine
  • Hematology
  • Infectious Diseases

Background:

  • HIV infection is a prothrombotic state, with venous thromboembolism (VTE) occurring at rates significantly higher than in the general population.
  • Studies indicate a two to tenfold increased risk of venous thrombosis in HIV-infected individuals.
  • Key risk factors include low CD4(+) cell count, clinical AIDS, protein S deficiency, and protein C deficiency.

Purpose of the Study:

  • To highlight the increased risk of VTE in HIV-infected patients.
  • To inform healthcare providers about recognizing and managing thrombotic complications in HIV care.
  • To emphasize the need for vigilance regarding anticoagulation management in this population.

Main Methods:

  • Review of existing studies on VTE in HIV-infected patients.
  • Analysis of associated risk factors, including CD4 count, specific deficiencies, and controversial factors like protease inhibitors.
  • Consideration of clinical implications for diagnosis and treatment.

Main Results:

  • HIV infection confers a substantially elevated risk of VTE.
  • Low CD4 count, AIDS, and deficiencies in proteins S and C are strongly associated with VTE.
  • Controversial risk factors include protease inhibitor therapy, opportunistic infections, and antiphospholipid antibodies.

Conclusions:

  • HIV-positive patients face a heightened risk of thrombotic events, necessitating proactive management.
  • Pulmonary embolism should be considered in HIV/AIDS patients with unexplained respiratory symptoms.
  • Healthcare providers must be aware of potential drug interactions between anticoagulants (e.g., warfarin) and antiretroviral therapies, monitoring INR closely.